Abstract:Background: Matrix metalloproteinase-7 (MMP-7) holds great promise as a diagnostic marker for biliary atresia (BA). This study aimed to establish reference values of serum MMP-7 and explore a novel measurement approach using dried blood spot (DBS).Methods: This was a single-center diagnostic test. Serum and DBS MMP-7 concentrations were measured using an ELISA kit. Intraoperative cholangiography and subsequent histological examinations were used to confirm BA diagnoses.Findings: 176 infants without hepatobiliary diseases were enrolled in the control group. The median serum MMP-7 concentration was 7.53 ng/mL (IQR: 5.58, 10.26) compared with 13.82 ng/mL (IQR: 8.10, 19.80) in the neonatal subgroup. 568 cholestatic infants were enrolled, including 318 patients in the retrospective cohort and 250 in the prospective cohort. Using a cutoff value of 18 ng/mL, the area under the ROC curve (AUC) for the retrospective cohort was 0.967 (95% confidence interval [CI]: 0.947–0.988), with a sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 93.0%, 93.8%, 94.7%, and 91.9%, respectively. The model was prospectively validated and achieved a diagnostic sensitivity of 94.8% (146/154; 95%CI: 89.7%–97.6%), specificity of 87.0% (80/92; 95%CI: 77.9%–92.8%), PPV of 92.4% (146/158; 95%CI: 86.8%–95.8%), and NPV of 90.9% (80/88; 95%CI: 82.3%–95.7%). 136 samples were tested via both DBS and serum. Linear regression showed that DBS MMP-7 levels correlated well with serum results (R = 0.942, P < 0.001).Interpretation: MMP-7 levels can precisely diagnose BA. A reference range and cutoff value were established, which were higher in neonates. DBS could be an alternative approach to measuring MMP-7.Clinical Trial Registration Details: Prospectively registered at http://www.chictr.org.cn/ (ChiCTR2000032983).Funding Information: This study received financial support from Clinical Research Plan of SHDC (no. SHDC2020CR2009A), Shanghai Municipal Key Clinical Specialty (no. shslczdzk05703), National Natural Science Foundation of China (no. 81770519, no. 81771633, no. 81873545 and no. 81974059), The Science Foundation of Shanghai (no. 18411969100 and no. 19ZR1406600), and Children's National Medical Center (no. EK1125180104, no. EKYY20180204, EK112520180211 and no. EK112520180310).Declaration of Interests: Jiale Deng, Dake Yang, Weiwei Xiang, Xianghui Zhang and Zhuo Fang work for WuXi Diagnostics. All authors declared no other conflicts of interest.Ethics Approval Statement: This study was reviewed and approved by the Ethics Committee of Children’s Hospital of Fudan University (No.: 2020-296). This work was performed in compliance with the Declaration of Helsinki and other relevant regulations. Informed consent was obtained from the guardian of each participant before enrollment.

Correlation analysis of MMP-7, APRI and liver fibrosis in biliary atresia

Accurate Prediction of Biliary Atresia with an Integrated Model Using MMP-7 Levels and Bile Acids.

FIB-4 and APRI scores for progressive liver fibrosis diagnosis in children with biliary atresia

Serum MMP-7 in the Diagnosis of Biliary Atresia

Clinical Characteristics and Prognosis of Biliary Atresia with Low Serum Matrix Metalloproteinase-7 Levels.

The Aberrant Expression of HLA-DR in Intrahepatic Bile Ducts in Patients with Biliary Atresia: an Immunohistochemistry and Immune Electron Microscopy Study.

Biomarkers for the diagnosis and post-Kasai portoenterostomy prognosis of biliary atresia: a systematic review and meta-analysis

Correlation of Interleukin-33/ST2 Receptor and Liver Fibrosis Progression in Biliary Atresia Patients.

Diagnostic accuracy of serum matrix metalloproteinase-7 as a biomarker of biliary atresia in a large North American cohort

Serum matrix metalloproteinase-7 for discriminating biliary atresia: a diagnostic accuracy and validation study

Progress in Biomarkers Related to Biliary Atresia

Reference Values of Serum MMP-7 and a Novel Measurement Approach Using Dried Blood Spot: A Diagnostic Test for Biliary Atresia

Protocol for a Diagnostic Accuracy Study to Develop Diagnosis Algorithm for Biliary Atresia Using MMP-7 (DIABA-7 Study): a Study Recruiting from Chinese Biliary Atresia Collaborative Network

Serum matrix metalloproteinase 7 as a diagnostic and prognostic biomarker for extrahepatic biliary atresia

Value of serum matrix metalloproteinase-7 in the differential diagnosis of obstructive jaundice: a multicenter diagnostic trial

Multicenter study of prognostic factors for biliary atresia

Correlation between hepatic oxidative damage and clinical severity and mitochondrial gene sequencing results in biliary atresia.

Serum TGF-β1 and VEGF Levels Reflect the Liver Hardness and Function in Children with Biliary Atresia

Hepatic ADC map as an adjunct to conventional abdominal MRI to evaluate hepatic fibrotic and clinical cirrhotic severity in biliary atresia patients

Hepatic Expression of Interleukin 8 in Diagnosing Biliary Atresia

Metabonomics Reveals Metabolite Changes in Biliary Atresia Infants